Four Thought Financial Partners, LLC Abb Vie Inc. Transaction History

Four Thought Financial Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $7,191 - $8,194	-45 Reduced 0.25%	18,205 $3.32 Billion
Q4 2023 Feb 06, 2024	BUY	$137.6 - $154.97 $4,540 - $5,114	33 Added 0.18%	18,250 $2.83 Billion
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $107,139 - $124,029	802 Added 4.61%	18,217 $2.72 Billion
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $50,353 - $62,662	-380 Reduced 2.14%	17,415 $2.35 Billion
Q1 2023 May 04, 2023	BUY	$144.61 - $166.54 $4,338 - $4,996	30 Added 0.17%	17,795 $2.84 Billion
Q4 2022 Feb 07, 2023	BUY	$138.31 - $165.87 $2.46 Million - $2.95 Million	17,765 New	17,765 $2.87 Billion

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Four Thought Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Four Thought Financial Partners, LLC with notifications on news.